Conference abstract · 17 Nov 2015
Conference abstractPublished 17 Dec 2014
Improvement of ω-3 fatty acids-rich supplement on perioperative immune responses in patients undergoing cardiac surgery
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We conducted a pilot study in patients undergoing cardiac surgery to investigate the influence of a dietary supplement enriched in omega-3 fatty acids on immune responses. Patients in the supplement group (n=7) received a dietary supplement enriched in ω-3 fatty acids, namely Impact® for 5 successive days before surgery; those in the control group (n=7) did not receive Impact®. Blood samples in both groups were collected at same time points. Before surgery, samples were collected on 5 days before surgery at the start of supplementation (baseline) and the end of supplementation (postoperative day (POD)-0). After surgery, samples were collected on POD-1 and POD-7. The expression of human leukocyte antigen (HLA)-DR, the ratio of CD4-/CD8-positive cells, the production of IFN-γ by CD4-positive cells, plasma levels of cytokines, and leukocyte-platelet aggregates were measured. Before surgery (POD-0), the supplement caused significant increases in HLA-DR expression, CD4/ CD8 ratio, and plasma levels of IFN-γ; these levels were significantly higher compared to those in the control group (p<0.01, respectively). After surgery (POD-1), all values dramatically decreased in comparison with those of POD-0; however, the values in the supplement group were significantly higher compared to their respective markers in the control group (p<0.05, respectively). Significant differences of HLA-DR expression and CD4/CD8 ratio persisted through POD-7. Before surgery (POD-0), plasma levels of IL-10 in the supplement group decreased significantly compared with those in the control group (p<0.05). After surgery (POD-1), plasma levels of IL-10 in both the control and supplement groups increased; these levels in the supplement group were significantly lower than those in the control group (p<0.01). Significant decreases in the percentage of leukocyte-platelet aggregates were found after supplementation; the difference between the supplement and the control groups was found on POD-0 and POD-1 (P<0.01, respectively). In conclusion, the dietary supplement increased HLA-DR expression, the CD4/CD8 ratio, and the production of IFN-γ by CD4-positive cells; conversely, the levels of IL-10 and the formation of leukocyte-platelet aggregates before and after surgery were suppressed. These beneficial effects may decrease the incidence of complications after surgery.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 30 Apr 2017
Effects of Polyunsaturated Fatty Acids on Immune Response of Avian
Research article · 3 May 2019
Croton bonplandianum Baill. : A rich source of essential fatty acids, linoleic and linolenic acid
Research article · 3 May 2019
Study on Protective Effect of Omega -3 Fatty Acid Rich Extract of Linium Usitatissimum Seeds on Cisplatin Induced Nephrotoxicity
Research article · 2016
Corchorus Olitorius Linn: A Rich Source of Ω3-Fatty Acids
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kazuo Nakamura”
